Evidence map›Paper›PMID 41075116›Full record

ArticleRadiological physics and technology2025

Quantitative evaluation of entrance skin dose from kV imaging in respiratory motion-tracking radiotherapy.

Yosuke Miyauchi, Shogo Tsunemine, Tetsuya Tomida, Masumi Numano, Kazuaki Funamoto, Shuichi Ozawa, Satoru Sugimoto, Hideyuki Harada

Abstract read
PubMed Publisher
In one paragraph

Article in Radiological physics and technology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yosuke MiyauchiDepartment of Radiation and Proton Therapy Office, Shizuoka Cancer Center, Shizuoka, 411-8777, Japan. y.miyauchi@scchr.jp.ORCID http://orcid.org/0009-0000-0825-3588
Shogo TsunemineDepartment of Radiation and Proton Therapy Office, Shizuoka Cancer Center, Shizuoka, 411-8777, Japan.
Tetsuya TomidaDepartment of Radiation and Proton Therapy Office, Shizuoka Cancer Center, Shizuoka, 411-8777, Japan.
Masumi NumanoDepartment of Radiation and Proton Therapy Office, Shizuoka Cancer Center, Shizuoka, 411-8777, Japan.
Kazuaki FunamotoDepartment of Radiation and Proton Therapy Office, Shizuoka Cancer Center, Shizuoka, 411-8777, Japan.
Shuichi OzawaHiroshima High-Precision Radiotherapy Cancer Center, Hiroshima, Japan.
Satoru SugimotoMedical Data Mathematical Reasoning Team, Advanced Data Science Project, Information R&D and Strategy Headquarters, RIKEN, Yokohama, Kanagawa, Japan.
Hideyuki HaradaDepartment of Radiation and Proton Therapy Center, Shizuoka Cancer Center, Shizuoka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although some studies have reported the radiation doses associated with kilovoltage (kV) X-ray imaging in motion-tracking radiotherapy using Radixact Synchrony, detailed assessments of skin doses that reflect the actual imaging frequency and patient positioning remain insufficient. This study aimed to estimate the entrance skin dose (ESD) associated with frequent kV image acquisition, evaluate the radiation dose in past patients at our hospital, and identify the contribution of imaging dose relative to the prescription dose and dose constraints. For each protocol available on the Radixact Synchrony system, the half-value layer, X-ray tube voltage, and air kerma at the kV imaging isocenter were measured using a semiconductor detector (RaySafe X2, Unfors RaySafe AB, Sweden). The ESD associated with the kV image acquisition was estimated based on the number of kV image acquisitions during tracking and corresponding imaging angles from 109 patients who underwent motion-tracking radiotherapy. The total number of imaging exposures throughout the treatment period averaged 1230 per patient, with a maximum of 3750. The cumulative ESD per acquisition angle averaged 69.1 mGy, with a maximum of 367.2 mGy. Furthermore, by considering the overlap of imaging angles and the influence of transmitted X-rays, the estimated maximum skin dose was 951.9 mGy. In this case, the maximum skin dose in the treatment plan was 47.9 Gy, and so the imaging dose corresponded to approximately 2% of the prescribed skin dose. Our findings indicate that the contribution of the imaging dose to the treatment dose is sufficiently low.

Indexed as

Radiation DosageRadiotherapy, Image-GuidedRespirationSkinAgedFemaleHumansMaleMiddle AgedMovementRadiotherapy DosageTomography, X-Ray ComputedEntrance skin doseImage-guided radiotherapykV imagingMotion-tracking radiotherapy

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.